GoodRx HoldingsGDRX +3.70%65 FCF Yield % is 10.18 as of Jun. 28, 2026, which is 177% above its 10-year median of 3.68. GuruFocus rates GDRX with a GF Score™ of 65/100 and a GF Value™ of $5.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 687 Healthcare Providers & Services companies, GoodRx Holdings ranks better than 82.97% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
GoodRx Holdings FCF Yield % Related Terms
GoodRx Holdings FCF Yield % Historical Data
* Premium members only.
The historical data trend for GoodRx Holdings's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, GoodRx Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GoodRx Holdings FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's FCF Yield % distribution charts can be found below:
* The bar in red indicates where GoodRx Holdings's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GoodRx Holdings (GDRX) has a FCF Yield % of 10.18 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on GoodRx Holdings and its competitors. This is 177% above median its historical median of 3.68. Over the past decade, GoodRx Holdings' FCF Yield % has ranged from 0.42 to 14.61. According to the industry distribution chart, GoodRx Holdings ranks #117 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 17%.
Is GoodRx Holdings' FCF Yield % too high?
GoodRx Holdings' current FCF Yield % of 10.18 is 177% above median its 10-year median of 3.68. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 14.61. The Healthcare Providers & Services industry median FCF Yield % is 1.91. GoodRx Holdings' value of 10.18 is 433% above this industry median. Based on the distribution chart, GoodRx Holdings ranks #117 out of 687 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, GoodRx Holdings has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GoodRx Holdings' FCF Yield % compare to OMDA and CERT?
According to the Healthcare Providers & Services industry distribution chart, GoodRx Holdings ranks #117 out of 687 companies for FCF Yield %. This places GoodRx Holdings in the top 17% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.91. GoodRx Holdings' value of 10.18 is 433% above this benchmark. Historically, GoodRx Holdings' own FCF Yield % has ranged from 0.42 to 14.61 over the past decade. While the company's 10-year median is 3.68 vs. the industry median of 1.91, GoodRx Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.91, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GoodRx Holdings's current FCF Yield % of 10.18 is 433% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on GoodRx Holdings and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GoodRx Holdings's current FCF Yield % is 10.18, which is 177% above median its own 10-year median of 3.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GoodRx Holdings stock overvalued right now?
Based on GuruFocus' analysis, GoodRx Holdings (GDRX) is currently considered Possible Value Trap. The stock's GF Value™ is $5.66, compared to a current price of $2.80 — trading 50.5% below its estimated fair value. The current FCF Yield % is 10.18, which is 177% above median its 10-year median of 3.68 and 433% above the Healthcare Providers & Services industry median of 1.91. GoodRx Holdings' overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For GoodRx Holdings (GDRX), the current FCF Yield % is 10.18 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GoodRx Holdings (GDRX) Overvalued in 2026?
Based on GuruFocus' analysis, GoodRx Holdings stock appears to be undervalued.
The current stock price of $2.80 is trading 50.5% below its estimated GF Value™ of $5.66.
GuruFocus considers GoodRx Holdings to be Possible Value Trap.
Key valuation signals for GDRX:
FCF Yield %: 10.18 (177% above median its 10-year median of 3.68)
GF Value™: $5.66 vs. price of $2.80 (50.5% below fair value)
Industry Position: 433% above the Healthcare Providers & Services median (#117 of 687)
No single metric tells the full story. See the GDRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
65GF Score
Get the complete analysis for GDRX
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GDRX has been successfully added to your 
